Aurobindo Pharma Dividends and Buybacks
Dividend criteria checks 2/6
Aurobindo Pharma is a dividend paying company with a current yield of 0.24% that is well covered by earnings.
Key information
0.2%
Dividend yield
1.3%
Buyback Yield
| Total Shareholder Yield | 1.5% |
| Future Dividend Yield | 0.4% |
| Dividend Growth | 4.8% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | ₹3.000 |
| Payout ratio | 2% |
Recent dividend and buyback updates
Recent updates
Earnings Miss: Aurobindo Pharma Limited Missed EPS By 14% And Analysts Are Revising Their Forecasts
Nov 12
Insufficient Growth At Aurobindo Pharma Limited (NSE:AUROPHARMA) Hampers Share Price
Oct 20Estimating The Intrinsic Value Of Aurobindo Pharma Limited (NSE:AUROPHARMA)
Sep 10This Is Why Aurobindo Pharma Limited's (NSE:AUROPHARMA) CEO Can Expect A Bump Up In Their Pay Packet
Aug 23Earnings Update: Here's Why Analysts Just Lifted Their Aurobindo Pharma Limited (NSE:AUROPHARMA) Price Target To ₹1,422
Aug 13Here's Why Aurobindo Pharma (NSE:AUROPHARMA) Can Manage Its Debt Responsibly
Jun 20Aurobindo Pharma Limited (NSE:AUROPHARMA) Released Earnings Last Week And Analysts Lifted Their Price Target To ₹1,271
May 29Is Aurobindo Pharma Limited (NSE:AUROPHARMA) Expensive For A Reason? A Look At Its Intrinsic Value
May 22Aurobindo Pharma Limited's (NSE:AUROPHARMA) Earnings Are Not Doing Enough For Some Investors
Apr 10Is Aurobindo Pharma Limited (NSE:AUROPHARMA) Worth ₹1.1k Based On Its Intrinsic Value?
Jan 14Aurobindo Pharma (NSE:AUROPHARMA) Has A Pretty Healthy Balance Sheet
Dec 27Is Aurobindo Pharma Limited (NSE:AUROPHARMA) Expensive For A Reason? A Look At Its Intrinsic Value
Sep 07Is Aurobindo Pharma (NSE:AUROPHARMA) A Risky Investment?
Jun 14Is Aurobindo Pharma Limited (NSE:AUROPHARMA) Trading At A 29% Discount?
May 21Aurobindo Pharma Limited's (NSE:AUROPHARMA) Intrinsic Value Is Potentially 93% Above Its Share Price
Feb 11Aurobindo Pharma (NSE:AUROPHARMA) Seems To Use Debt Quite Sensibly
Jan 09Is There An Opportunity With Aurobindo Pharma Limited's (NSE:AUROPHARMA) 50% Undervaluation?
Nov 02We Think Aurobindo Pharma (NSE:AUROPHARMA) Can Stay On Top Of Its Debt
Jun 20Stability and Growth of Payments
Fetching dividends data
Stable Dividend: AUROPHARMA's dividend payments have been volatile in the past 10 years.
Growing Dividend: AUROPHARMA's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Aurobindo Pharma Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (AUROPHARMA) | 0.2% |
| Market Bottom 25% (IN) | 0.2% |
| Market Top 25% (IN) | 1.2% |
| Industry Average (Pharmaceuticals) | 0.7% |
| Analyst forecast (AUROPHARMA) (up to 3 years) | 0.4% |
Notable Dividend: AUROPHARMA's dividend (0.24%) isn’t notable compared to the bottom 25% of dividend payers in the Indian market (0.25%).
High Dividend: AUROPHARMA's dividend (0.24%) is low compared to the top 25% of dividend payers in the Indian market (1.15%).
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (2.4%), AUROPHARMA's dividend payments are thoroughly covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: AUROPHARMA is paying a dividend but the company has no free cash flows.